Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 499 across all filing types
Latest filing 2024-10-02 Director's Dealing
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Ledende medarbejderes transaktioner
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions conducted by persons discharging managerial responsibilities (PDMRs) and their closely associated persons, as required by the EU Market Abuse Regulation (MAR). It details the name of the entity (Nordic Compound Invest A/S), the issuer (Orphazyme A/S), the nature of the transaction (purchase of shares), the price, quantity, and date. This falls under the category of Director's Dealing (DIRS).
2024-10-02 Danish
Ledende medarbejderes transaktioner
Director's Dealing Classification · 98% confidence The document title 'Ledende medarbejderes transaktioner' translates to 'Transactions by persons discharging managerial responsibilities' (PDMR). The text is very short (under 5,000 characters) and serves as a cover note directing the reader to attached files containing the actual transaction notifications. According to the 'Menu vs Meal' rule, this is a notification/announcement of the filings rather than the filings themselves, and it specifically pertains to director/executive dealings.
2024-10-02 Danish
Director's Dealing 2024
Director's Dealing Classification · 98% confidence The document text is structured as a template or form detailing how transactions executed by persons discharging managerial responsibilities (PDMRs) and their closely associated persons must be reported and made public. The headings explicitly mention 'person med ledelsesansvar' (person with managerial responsibility) and 'transaktioner' (transactions). This structure strongly aligns with regulatory requirements for reporting insider trades or director's dealings, which corresponds to the 'Director's Dealing' category (DIRS). The document is not a full financial report (10-K, IR), an earnings release (ER), or a general announcement (RNS/RPA). It is a specific regulatory disclosure format concerning insider transactions.
2024-10-02 Danish
Ledende medarbejders transaktioner
Director's Dealing Classification · 100% confidence The document is a standard regulatory form used in Denmark (Finanstilsynet) for reporting transactions by persons discharging managerial responsibilities (PDMRs). It explicitly lists the name of the person (Michael Hove via MH Investment ApS), their title (Chairman), the issuer (Orphazyme A/S), and details of the share purchase (price, quantity, date). This falls under the category of Director's Dealing (DIRS).
2024-10-02 Danish
Ledende medarbejders transaktioner
Director's Dealing Classification · 100% confidence The document is a standard regulatory form (Finanstilsynet) used for reporting transactions by persons discharging managerial responsibilities (PDMRs) and their closely associated persons. It details specific share purchases by MH Investment ApS (associated with the Chairman, Michael Hove) in Orphazyme A/S. This falls directly under the definition of 'Director's Dealing' (DIRS).
2024-10-02 Danish
Ledende medarbejders transaktioner
Director's Dealing Classification · 95% confidence The document is a short announcement (Selskabsmeddelelse) from Orphazyme A/S regarding the trading of shares by board members or directors. The text explicitly states 'Se venligst vedlagte' (Please see attached), which indicates this is a notification of a transaction rather than the detailed transaction report itself. Given the subject matter is 'BESTYRELSESMEDLEMMERS, DIREKTØRERS ELLER NÆRTSTÅENDE PERSONERS HANDEL' (Trading by board members, directors, or related parties), it falls under the category of Director's Dealing.
2024-10-02 Danish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.